28 Mar 2017 13:29
Hardman Research: History is repeating itself
History is repeating itself - Arbuthnot's strategy, and largely the same management team, have delivered total shareholder returns of 418% 2008-2017 and 930% 1997-2017 respectively. 2016 saw a new phase in the execution of the strategy with the further partial sale of Secure Trust shares releasing capital to be deployed in other businesses. The initial stages of this deployment began (property acquisition, loan book purchase, accelerated team hires, asset finance deal, plus a 325p special dividend) but the full deployment of capital will take some years. 2016 results were a little ahead of our estimates but 2017 accelerated investment leaves forecasts largely unchanged.
Please click here for the full report:
http://hardmanandco.com/docs/default-source/company-docs/arbuthnot-banking-group-plc-documents/28.03.17-history-is-repeating-itself.pdf
To contact us: Hardman & Co 11/12 Tokenhouse Yard London EC2R 7AS | Contacts: Mark Thomas mt@hardmanandco.com Telephone: +44 20 7929 3399 Follow us on Twitter @HardmanandCo |
www.hardmanandco.com
About Hardman & Co: For the past 20 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.
Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.
Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.
Arbuthnot (ARBB)